Naloxone
ID: 9594CS25Q0020Type: Solicitation
Overview

Buyer

COURT SERVICES AND OFFENDER SUPERVISION AGENCYCOURT SERVICES AND OFFENDER SUPERVISION AGENCYCOURT SERVICES OFFENDER SUPV AGCYWASHINGTON, DC, 20004, USA

NAICS

Pharmaceutical Preparation Manufacturing (325412)

PSC

DRUGS AND BIOLOGICALS (6505)

Set Aside

Total Small Business Set-Aside (FAR 19.5) (SBA)
Timeline
  1. 1
    Posted Dec 30, 2024, 12:00 AM UTC
  2. 2
    Updated Jan 3, 2025, 12:00 AM UTC
  3. 3
    Due Jan 7, 2025, 7:00 PM UTC
Description

The Court Services and Offender Supervision Agency (CSOSA) is seeking proposals for the procurement of 450 packages of Naloxone 2 Dose Nasal Spray, as outlined in their solicitation. This procurement aims to ensure the availability of this critical medication, which is essential for reversing opioid overdoses, thereby supporting public health and safety initiatives. The contract will be awarded under a firm-fixed price purchase order, with a submission deadline for quotations set for January 7, 2025. Interested vendors can direct inquiries to Matthew Collins at matthew.collins@csosa.gov or by phone at 202-369-7635 for further details on compliance and submission requirements.

Point(s) of Contact
Files
Title
Posted
Jan 3, 2025, 11:08 PM UTC
This document is Amendment 0001 to Solicitation 9594CS25Q0020 issued by the Court Services and Offender Supervision Agency regarding the procurement of Naloxone. The amendment outlines the acknowledgment requirements for any proposals, which must be communicated via specific methods prior to the deadline. It details the necessary contractor information to be included in submissions, replacing section L.1.2, which now specifies required details such as the contractor's contact information, Tax Identification Number, Unique Entity Identification, Cage Code, and a validity statement for the quotation. Additionally, a new section L.1.3 mandates information about the manufacturer of the quoted product. The amendment emphasizes that acknowledgment of receipt must be submitted with proposals to avoid rejection due to noncompliance. Overall, this document aims to clarify submission requirements and ensure compliance in the procurement process.
Jan 3, 2025, 11:08 PM UTC
The document outlines the Offeror Representations and Certifications required for federal solicitations, specifically focusing on commercial products and services. It details the criteria for small businesses, including those owned by economically disadvantaged women and service-disabled veterans, alongside requirements for various certifications, such as compliance with the Buy American Act and prohibitions on the use of certain telecommunications and technologies. The sections emphasize the necessity for offerors to confirm their business status, confirm integrity regarding federal contracts, disclose tax liabilities, report any previous contracts, and observe restrictions related to operations in Sudan and dealings with Iran. Overall, the document serves as a comprehensive guide for prospective contractors to ensure compliance with federal regulations and eligibility for government contracts while maintaining transparency and ethical business practices. The structured format allows offerors to indicate their compliance with specific requirements clearly, ensuring a thorough understanding of obligations under the given solicitation.
Jan 3, 2025, 11:08 PM UTC
The document outlines a federal solicitation for the procurement of 450 packages of Naloxone 2 Dose Nasal Spray by the Court Services and Offender Supervision Agency (CSOSA). It specifies the required specifications, delivery timelines, and the contractual agreement structure, categorized under a firm-fixed price purchase order. The primary NAICS code for this contract is 325412, indicating it involves pharmaceutical preparation manufacturing, with a small business size standard of 1,300 employees. Key points include the requirement for vendors to submit their quotations by January 7, 2025, and details about the invoice processing via the Department of Treasury's Invoice Processing Platform. The solicitation emphasizes compliance with various federal regulations and clauses surrounding contractor conduct, payment processing, and delivery expectations, ensuring the procurement services align with government standards. The document is structured into sections addressing requisition details, supplies, specifications, delivery instructions, and administrative requirements, guiding potential contractors through the bidding process while ensuring adherence to government procurement policies.
Lifecycle
Title
Type
Naloxone
Currently viewing
Solicitation
Similar Opportunities
USMS FY25 D07 Heavy Duty Sterile Gloves
Buyer not available
The U.S. Marshals Service, part of the Department of Justice, is seeking quotations for the procurement of heavy-duty nitrile sterile gloves, specifically designed for use during the transportation and management of prisoners in court settings. The solicitation, numbered 15M10225QA4700093, is set aside for small businesses and outlines detailed specifications for four glove sizes (medium, large, XL, XXL) along with required quantities and UPC codes. This procurement is crucial for ensuring safety and efficiency in prisoner management during judicial processes, with a performance period extending from April 28, 2025, to September 30, 2026. Interested vendors must comply with federal regulations and submit their proposals, including necessary certifications, to Jennifer Brite at jennifer.brite@usdoj.gov or Kate Oravitz-Weeks at Kathryn.Oravitz-Weeks@usdoj.gov.
Treatment Services Opportunity: Inpatient SUD
Buyer not available
The Administrative Office of the U.S. Courts is soliciting proposals for inpatient substance use disorder treatment services in the Western District of Washington. The contract, which will run from October 1, 2025, to September 30, 2026, includes options for four additional 12-month extensions and aims to provide comprehensive treatment for federal individuals under supervision, including services such as urine collection, counseling, detoxification, and residential placement. This procurement is crucial for addressing the needs of individuals with substance use disorders, ensuring they receive appropriate care from certified and licensed professionals. Interested vendors must contact Angela McGlynn at 206-437-2281 or via email at angelamcglynn@wawp.uscourts.gov within 30 days of this announcement to express their interest and obtain further details.
Ondansetron 4MG and 8MG
Buyer not available
Presolicitation DEPT OF DEFENSE is planning to issue a national requirements contract for Ondansetron. This contract will establish a national supply source to provide Ondansetron HCL 4 and 8MG Tablets for purchase by Department of Defense, Department of Veterans Affairs, Indian Health Service, and Bureau of Prisons customers. The contract will be a firm-fixed price, requirements type contract with a one-year base and four one-year options. The projected solicitation date is March of 2023.
6509--Solifenacin Tabletes (VA-25-00037090)
Buyer not available
The Department of Veterans Affairs (VA) is preparing to issue a Request for Proposal (RFP) for the procurement of Solifenacin Tablets, aimed at ensuring a reliable supply for the VA, Department of Defense (DoD), and other federal health agencies. This unrestricted procurement will award one contract with a term of one year plus four optional renewal periods, requiring offerors to provide specific labeling, packaging details, and compliance with the Drug Supply Chain Security Act. The estimated annual requirements include various packaging sizes and quantities of Solifenacin, reflecting the VA's commitment to maintaining a consistent supply of essential medications for veterans and associated healthcare providers. Interested vendors should monitor SAM.gov for the solicitation release on or around March 14, 2025, with a response deadline of March 28, 2025; inquiries can be directed to Kenneth Lay at Kenneth.Lay@va.gov or by phone at 708-786-4879.
Duloxetine HCL DR Capsules
Buyer not available
The Defense Logistics Agency (DLA) is planning to issue a solicitation for a national requirements contract for Duloxetine HCL DR Capsules, which includes various dosages and packaging options. This procurement aims to establish a reliable national supply source for these pharmaceutical products, which are critical for the Department of Defense, Department of Veterans Affairs, Indian Health Service, and Bureau of Prisons. The contract will be a firm-fixed price, requirements type contract with a one-year base and four one-year options, and is expected to be solicited in April 2025. Interested parties should direct inquiries to Christopher Newman at christopher.newman@dla.mil or 445-737-7371, and are encouraged to monitor the DLA Bid Board System and Sam.Gov for updates.
6505--Hydroxychloroquine SO4 Tablets
Buyer not available
The Department of Veterans Affairs is soliciting offers for the procurement of Hydroxychloroquine SO4 Tablets, specifically 200mg tablets, through its National Acquisition Center. The solicitation outlines the requirements for supply contracts, including compliance with Good Manufacturing Practices (cGMP) and the Drug Supply Chain Security Act (DSCSA), as well as the need for a unique National Drug Code (NDC) for each product. This procurement is crucial for ensuring a consistent supply of pharmaceuticals to government healthcare facilities, thereby maintaining availability and pricing stability. Interested contractors should note that the deadline for submitting offers has been extended to April 8, 2025, at 2:30 PM CDT, and can reach out to Contract Specialist Christopher Carthron at Christopher.Carthron@va.gov for further inquiries.
6505--770_Pharmaceuticals_VA CMOP National Office_36C77025Q0196 770-25-3-801-0371 -National CMOP A1222 ACAMPROSATE TAB
Buyer not available
The Department of Veterans Affairs is seeking vendors to provide Acamprosate Calcium 333mg EC tablets under solicitation number 36C77025Q0196 for delivery to multiple Consolidated Mail Outpatient Pharmacy (CMOP) facilities. The procurement includes specific quantities of the pharmaceuticals, with a total of six different shipment requirements outlined, emphasizing compliance with the Drug Supply Chain Security Act (DSCSA) and adherence to federal regulations regarding pharmaceutical distribution. This opportunity is critical for ensuring the availability of essential medications for veterans' healthcare, reflecting the VA's commitment to quality and regulatory compliance in its supply chain. Interested vendors must submit their quotes, including a signed Standard Form 1449, a detailed price schedule in Excel format, and a state wholesale distributor license by April 9, 2025, with the estimated award date set for April 14, 2025. For further inquiries, vendors can contact Michael W McAlhaney at Michael.McAlhaney@va.gov or by phone at (913) 684-0134.
15BCTS25R00000004 SU/MH in Albany, NY
Buyer not available
The U.S. Department of Justice, through the Federal Bureau of Prisons, is soliciting proposals for the provision of Substance Use, Mental Health, and Sex Offender treatment services for male and female offenders in Albany, New York. The contract, which spans five years starting July 1, 2025, aims to deliver evidence-based treatment programs that reduce recidivism and improve mental health outcomes, adhering to strict compliance and documentation standards as outlined in the Statement of Work. This initiative is crucial for facilitating the reintegration of offenders into society while ensuring public safety and accountability. Interested contractors must submit their proposals by April 21, 2025, and can contact Yasmin Ramos-Maness at yramos-maness@bop.gov or Robert Carroll at r1carroll@bop.gov for further information.
SU/MH/SOT in Portland, OR.
Buyer not available
The Department of Justice, specifically the Federal Bureau of Prisons, is seeking quotes from qualified sources to provide community-based outpatient substance use disorder, mental health treatment, and sex offender treatment services for adults in custody in Portland, Oregon. The services must be delivered by licensed clinicians within a 10-mile radius of Portland City Hall and include a range of treatment options such as individual counseling, group counseling, and crisis intervention, with a contract performance period starting July 1, 2025, and potentially extending through June 30, 2030. Interested parties should monitor the General Services Administration’s Sam.gov website for the solicitation, expected to be released around April 21, 2025, and submit their quotes by the estimated closing date of May 21, 2025, at 12 pm EST. For inquiries, contact Joo Walker at j15walker@bop.gov or Robert Carroll at r1carroll@bop.gov.
Second Chance Act Goods and Services Pre-Solicitation Notice
Buyer not available
Presolicitation notice: ADMINISTRATIVE OFFICE OF THE US COURTS is seeking goods and services related to Outpatient Mental Health and Substance Abuse Centers. The federal Judiciary intends to procure treatment services and/or Second Chance Act goods and services for federal defendants and persons under supervision using Blanket Purchase Agreements. The services may include urine collection, counseling, physical examinations, detoxification, residential treatment, and transportation. The goods and services may include cognitive behavioral therapy, child-care, medical services, computer hardware/software, identification, transportation, transitional housing, domestic violence intervention, and job training. The specific services and requirements will be identified in the solicitation for Blanket Purchase Agreements.